INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF

INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF

ETF · US45782C7636 · BOUT (ARCX)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF
No Price
28.04.2026 19:54
Current Prices from INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF
ExchangeTickerCurrencyLast TradePriceDaily Change
XASE: AMEX
AMEX
BOUT
USD
28.04.2026 19:54
43,48 USD
-0,64 USD
-1,46 %
XNYS: NYSE
NYSE
BOUT
USD
28.04.2026 18:27
43,50 USD
-0,63 USD
-1,42 %
IEXG: IEX
IEX
BOUT
USD
24.04.2026 19:57
43,79 USD
-
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 313.758,00
Asset Allocation
AssetPercentage %
Stock US90,30 %
Stock non-US8,70 %
Cash1,01 %
NotClassified0,00 %
Other0,00 %
Bond0,00 %
Largest Positions
SymbolISINNamePercentage %
CRLCharles River Laboratories International Inc 3,07 %
MPWRMonolithic Power Systems Inc 3,03 %
MXLMaxLinear Inc 2,95 %
MIMEMimecast Limited 2,93 %
MSCIMSCI Inc 2,91 %
LECOLincoln Electric Holdings Inc 2,91 %
RCIIRent-A-Center Inc 2,90 %
SCHWThe Charles Schwab Corporation 2,90 %
CFLTConfluent Inc. Class A Common Stock 2,90 %
IRIngersoll Rand Inc 2,85 %
Region Distribution
RegionPercentage %
North America96,02 %
United Kingdom2,43 %
Australasia0,91 %
Africa/Middle East0,64 %
Asia Developed0,00 %
Asia Emerging0,00 %
Europe Developed0,00 %
Europe Emerging0,00 %
Japan0,00 %
Latin America0,00 %
Sector Distribution
SectorPercentage %
Industrieunternehmen33,40 %
Verbrauchsgüter16,24 %
Technologie16,16 %
Finanzdienstleistungen12,84 %
Grundstoffe10,64 %
Gesundheitswesen9,59 %
Basiskonsumgüter0,81 %
Immobilien0,31 %
Telekommunikation0,00 %
Energie0,00 %
Company Profile for INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF ETF
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified.
Fund Master Data
Issuer Innovator
Asset Class ETF
Name Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF
Fund Currency USD
Category Mid-Cap Growth
Fund Key Figures
Fund Size 16.653,45 EUR
Investment Strategy
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the index). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to break out, or experience a period of sustained price growth beyond the stock's recent resistance level, with consideration for various market conditions. The fund is non-diversified.

Company Data

Name INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF
Company Innovator IBD Breakout Opportunities ETF
Symbol BOUT
Website https://www.innovatoretfs.com/etf/?ticker=BOUT
Primary Exchange ARCX NYSE
ISIN US45782C7636
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 14 Mio
Country United States of America
Currency USD
Employees -
IPO Date 2018-09-13
Dividends from 'INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF'
Ex-Date Dividend per Share
31.12.2025 0,12 USD
31.12.2024 0,23 USD
31.07.2024 0,006 USD
28.12.2023 0,44 USD
29.12.2022 0,40 USD
27.12.2018 0,04 USD

Stock Splits

Date Split
02.09.2011 35:1

Ticker Symbols

Name Symbol
NYSE BOUT
More Shares
Investors who hold INNOVATOR IBD BREAKOUT OPPORTUNITIES ETF also have the following shares in their portfolio:
Fonterra Shareholders Fund
Fonterra Shareholders Fund Fund
TENAX THERAP.NEW DL-,0001
TENAX THERAP.NEW DL-,0001 Share